REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
13/06/2026
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Snapshot rápido
MOLECULAR MICROSCOPE
ST13
US500000086166255Classe
Pedido
Registro
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Fundamento do pedido
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Titulares
Representantes
Connie L. Ellerbach Fenwick & West LLP
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 44
Providing integrated diagnostic system services comprised of quantitative RNA services comprised of quantitative RNA measurement technologies including microarrays and RT-PCR to assess the disease states in tissue biopsies; Diagnostic testing using molecular diagnostic technology; Provision of diagnostic system services comprised of quantitative RNA measurement technologies including microarrays and RT-PCR to assess tissue biopsies by measuring RNA, mRNA and micro RNA expressions; Providing moleculor diagnostic testing services; Providing molecular diagnostic testing services on tissue biopsies; Providing diagnostic testing and assessment services relating to the assessment of tissue biopsies for disease diagnosis, activity, stage, potential for therapy (theranostics), response to therapy, prognosis and treatment; Converting RNA measurements into diagnostic information to assess the biopsy for diagnosis, activity, stage, potential for therapy (theranostics), response to therapy, and prognosis of the patient; Providing data analysis services in the field of diagnostic testing, assessment, management, analysis, and reporting; Providing medical diagnostic services featuring a virtual integrated diagnostic system that uses molecular technology to assess the disease state in tissue biopsies
Histórico de despachos e eventos da marca no USPTO.
66 publicações encontradas
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
13/06/2026
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/12/2023
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/12/2023
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/12/2023
TEAS SECTION 8 & 15 RECEIVED
09/06/2023
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
13/06/2022
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/12/2017
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/12/2017
REGISTERED-PRINCIPAL REGISTER
13/06/2017
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/03/2017
PUBLISHED FOR OPPOSITION
28/03/2017
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/03/2017
LAW OFFICE PUBLICATION REVIEW COMPLETED
22/02/2017
APPROVED FOR PUB - PRINCIPAL REGISTER
22/02/2017
EXAMINER'S AMENDMENT ENTERED
31/01/2017
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
27/01/2017
EXAMINERS AMENDMENT E-MAILED
27/01/2017
EXAMINERS AMENDMENT -WRITTEN
27/01/2017
NOTIFICATION OF NON-FINAL ACTION E-MAILED
18/01/2017
NON-FINAL ACTION E-MAILED
18/01/2017
NON-FINAL ACTION WRITTEN
18/01/2017
PREVIOUS ALLOWANCE COUNT WITHDRAWN
19/12/2016
WITHDRAWN FROM PUB - OG REVIEW QUERY
13/12/2016
LAW OFFICE PUBLICATION REVIEW COMPLETED
29/11/2016
ASSIGNED TO LIE
17/11/2016
APPROVED FOR PUB - PRINCIPAL REGISTER
15/11/2016
TEAS/EMAIL CORRESPONDENCE ENTERED
31/10/2016
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/10/2016
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
25/10/2016
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
21/06/2016
LETTER OF SUSPENSION E-MAILED
21/06/2016
SUSPENSION LETTER WRITTEN
21/06/2016
TEAS/EMAIL CORRESPONDENCE ENTERED
14/06/2016
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/06/2016
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
27/05/2016
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/12/2015
LETTER OF SUSPENSION E-MAILED
01/12/2015
SUSPENSION LETTER WRITTEN
01/12/2015
TEAS/EMAIL CORRESPONDENCE ENTERED
30/11/2015
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/11/2015
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
18/11/2015
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/06/2015
LETTER OF SUSPENSION E-MAILED
12/06/2015
SUSPENSION LETTER WRITTEN
12/06/2015
TEAS/EMAIL CORRESPONDENCE ENTERED
14/05/2015
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/05/2015
ASSIGNED TO LIE
11/05/2015
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
07/05/2015
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
24/11/2014
LETTER OF SUSPENSION E-MAILED
24/11/2014
SUSPENSION LETTER WRITTEN
24/11/2014
TEAS/EMAIL CORRESPONDENCE ENTERED
20/11/2014
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/11/2014
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/11/2014
NOTIFICATION OF NON-FINAL ACTION E-MAILED
13/11/2014
NON-FINAL ACTION E-MAILED
13/11/2014
NON-FINAL ACTION WRITTEN
13/11/2014
TEAS/EMAIL CORRESPONDENCE ENTERED
23/10/2014
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/10/2014
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/10/2014
NOTIFICATION OF NON-FINAL ACTION E-MAILED
24/04/2014
NON-FINAL ACTION E-MAILED
24/04/2014
NON-FINAL ACTION WRITTEN
24/04/2014
ASSIGNED TO EXAMINER
17/04/2014
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/01/2014
NEW APPLICATION ENTERED
18/01/2014
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.